Guardian Pharmacy Services, Inc.
For the period ended Dec 31, 2024. Filed Mar 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 of 15(d) the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Guardian Pharmacy Services, Inc. | ||
| Date: March 26, 2025 | By: | /s/ David K. Morris |
|---|---|---|
| David K. Morris Executive Vice President and Chief Financial Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Fred P. Burke Fred P. Burke | President and Chief Executive Officer and Director (Principal Executive Officer) | March 26, 2025 |
| /s/ David K. Morris David K. Morris | Executive Vice President, Chief Financial Officer and Director (Principal Financial Officer and Principal Accounting Officer) | March 26, 2025 |
| /s/ John Ackerman John Ackerman | Director | March 26, 2025 |
| /s/ William Bindley William Bindley | Director | March 26, 2025 |
| /s/ Steve Cosler Steve Cosler | Director | March 26, 2025 |
| /s/ Randall Lewis Randall Lewis | Director | March 26, 2025 |
| /s/ Mary Sue Patchett Mary Sue Patchett | Director | March 26, 2025 |
| /s/ Thomas Salentine, Jr. Thomas Salentine, Jr. | Director | March 26, 2025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.